Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1989-2-7
|
| pubmed:abstractText |
Serum samples collected from four groups of individuals in the Washington, D.C. area were examined for the presence of IgG and IgM classes of antibody reacting against HTLV-I and HIV-1. These four groups were: (1) healthy adults with negative premarital VDRL test for syphilis (n = 113), (2) miscellaneous common disease patients (n = 155), (3) drug abusers (n = 130), and (4) homosexual men (n = 187). The former two groups are considered to be low-risk groups, and the latter two, high-risk groups. The prevalence of IgG antibody on ELISA/Western blot tests for these groups were respectively: (1) 5.3%/1.8%, (2) 5.2%/1.9%, (3) 13.9%/4.6%, and (4) 4.3%/1.6% for HTLV-I, and (1) 2.7%/0.9%, (2) 4.5%/0%, (3) 12.3%/5.4%, and (4) 8.0%/5.9% for HIV-1. Instances of possible concomitant infection as shown by the presence of antibodies against both HTLV-I and HIV-1 were found only in the latter two high-risk groups, i.e. two (1.5%) in group (3), and three (1.6%) in group (4) as confirmed by both Western blot and immunofluorescence tests. Out of 97 sera collected from drug abusers in 1985-86 which had IgG antibody by Western blot test against HIV-1, 23 (23.7%) were HTLV-I antibody positive by ELISA test (Group 5), and 8 of these were confirmed by Western blot test. Among these 8 persons, IgM antibody against HTLV-I was found in 2, while that against HIV-1 was positive in 7 persons.(ABSTRACT TRUNCATED AT 250 WORDS)
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0393-2990
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
4
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
426-34
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:2904886-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:2904886-Adult,
pubmed-meshheading:2904886-Aged,
pubmed-meshheading:2904886-Blotting, Western,
pubmed-meshheading:2904886-Deltaretrovirus Infections,
pubmed-meshheading:2904886-District of Columbia,
pubmed-meshheading:2904886-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:2904886-Female,
pubmed-meshheading:2904886-Fluorescent Antibody Technique,
pubmed-meshheading:2904886-HIV,
pubmed-meshheading:2904886-HIV Antibodies,
pubmed-meshheading:2904886-HTLV-I Antibodies,
pubmed-meshheading:2904886-Homosexuality,
pubmed-meshheading:2904886-Human T-lymphotropic virus 1,
pubmed-meshheading:2904886-Humans,
pubmed-meshheading:2904886-Immunoglobulin G,
pubmed-meshheading:2904886-Immunoglobulin M,
pubmed-meshheading:2904886-Injections, Intravenous,
pubmed-meshheading:2904886-Male,
pubmed-meshheading:2904886-Middle Aged,
pubmed-meshheading:2904886-Random Allocation,
pubmed-meshheading:2904886-Retrospective Studies,
pubmed-meshheading:2904886-Substance-Related Disorders
|
| pubmed:year |
1988
|
| pubmed:articleTitle |
Concomitant infection of HTLV-I and HIV-1: prevalence of IgG and IgM antibodies in Washington, D.C. area.
|
| pubmed:affiliation |
Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, MD 20892.
|
| pubmed:publicationType |
Journal Article
|